Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any acute myeloid leukemia that has the chromosomal anomaly KRAS gene mutation. (A change in the nucleotide sequence of the KRAS gene.)
Biomarker and diagnostic research for acute myeloid leukemia, KRAS gene mutation has been reported in the published literature.
No clinical trials have been registered for acute myeloid leukemia, KRAS gene mutation.
43 publications have been identified in PubMed for acute myeloid leukemia, KRAS gene mutation. Research spans Basic Science / Preclinical (37%), Review / Meta-Analysis (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 16 | 37% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:08 PM UTC
Common questions about acute myeloid leukemia, KRAS gene mutation
Research summaries
7 |
16% |
Disease patterns and progression | 7 | 16% |
Testing and diagnosis research | 6 | 14% |
Clinical study results | 3 | 7% |
Other research | 2 | 5% |
Patient case studies | 2 | 5% |
Eslalakawi Y (2026). [PMID: 41804592](https://pubmed.ncbi.nlm.nih.gov/41804592/). *Cancer Control*. [Review / Meta-Analysis]
Jin H (2026). [PMID: 41386566](https://pubmed.ncbi.nlm.nih.gov/41386566/). *Br J Haematol*. [Epidemiology / Natural History]
Batayneh O (2026). [PMID: 41514668](https://pubmed.ncbi.nlm.nih.gov/41514668/). *Cancers (Basel)*. [Basic Science / Preclinical]
Wei AH (2026). [PMID: 41269778](https://pubmed.ncbi.nlm.nih.gov/41269778/). *Blood Adv*. [Clinical Trial Publication]
Shoji K (2026). [PMID: 41126738](https://pubmed.ncbi.nlm.nih.gov/41126738/). *Haematologica*. [Diagnostic / Biomarker]
Kamitori T (2026). [PMID: 42056531](https://pubmed.ncbi.nlm.nih.gov/42056531/). *Leukemia*. [Basic Science / Preclinical]
Guarnera L (2026). [PMID: 40983034](https://pubmed.ncbi.nlm.nih.gov/40983034/). *Blood*. [Epidemiology / Natural History]
Hao Y (2026). [PMID: 41777888](https://pubmed.ncbi.nlm.nih.gov/41777888/). *Front Immunol*. [Review / Meta-Analysis]
Cao HX (2025). [PMID: 41234068](https://pubmed.ncbi.nlm.nih.gov/41234068/). *Zhongguo Shi Yan Xue Ye Xue Za Zhi*. [Case Report / Case Series]
Huang BJ (2025). [PMID: 41292909](https://pubmed.ncbi.nlm.nih.gov/41292909/). *bioRxiv*. [Basic Science / Preclinical]